Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
4.950
-0.870 (-14.95%)
At close: Nov 7, 2025, 4:00 PM EST
4.900
-0.050 (-1.01%)
After-hours: Nov 7, 2025, 7:47 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $6.56 million as of November 7, 2025. Its market cap has decreased by -11.86% in one year.
Market Cap
6.56M
Enterprise Value
-992.43K
1-Year Change
-11.86%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $6.56M, a decrease of -98.22%. That is a compound annual growth rate of -55.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 6.56M | 7.06% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |